Nathan Todnem1, Ayobami Ward1, Michael Nahhas2, John R Vender1, Cargill H Alleyne3, Scott Y Rahimi4. 1. Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. 2. Department of Neurology, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. 3. Augusta Back Neuroscience Center, Augusta, Georgia, USA. 4. Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, Georgia, USA. Electronic address: srahmi@augusta.edu.
Abstract
BACKGROUND: The management of brain arteriovenous malformations (AVMs) remains a controversial topic. Given the relatively low incidence, high heterogeneity, and high morbidity and mortality of these lesions, consensus on treatment strategies is an issue of concern to organized neurosurgery. The present retrospective analysis examined and quantified the outcomes of patients with an initial presentation of intracranial hemorrhage from a Spetzler-Martin grade III or IV AVM, later ruled out as surgical candidates. METHODS: A total of 16 patients (5 females; 11 males) had presented with symptomatic hemorrhage confirmed by non-contrast-enhanced computed tomography and were deemed to not be surgical candidates owing to AVM location and/or architecture. The patients underwent combined endovascular embolization and gamma knife stereotactic radiosurgery (SRS). The modified Rankin scale was used to measure the clinical outcomes, comparing the scores at presentation, gamma knife treatment, and the last known follow-up examination. A radiographic evaluation was used to determine the level of AVM nidus involution after the procedure. RESULTS: The present study identified 16 patients with ruptured high-grade AVMs of high surgical risk. All the patients had undergone immediate embolization with delayed SRS for treatment of the hemorrhage and nidus of the AVM. A statistically significant proportion of patients showed marked improvement in the modified Rankin scale scores. No subsequent repeat hemorrhage or any associated complications after embolization occurred in any patient. CONCLUSION: These findings warrant consideration of endovascular embolization with adjuvant SRS as a powerful treatment option for cases with high surgical morbidity due to AVM characteristics.
BACKGROUND: The management of brain arteriovenous malformations (AVMs) remains a controversial topic. Given the relatively low incidence, high heterogeneity, and high morbidity and mortality of these lesions, consensus on treatment strategies is an issue of concern to organized neurosurgery. The present retrospective analysis examined and quantified the outcomes of patients with an initial presentation of intracranial hemorrhage from a Spetzler-Martin grade III or IV AVM, later ruled out as surgical candidates. METHODS: A total of 16 patients (5 females; 11 males) had presented with symptomatic hemorrhage confirmed by non-contrast-enhanced computed tomography and were deemed to not be surgical candidates owing to AVM location and/or architecture. The patients underwent combined endovascular embolization and gamma knife stereotactic radiosurgery (SRS). The modified Rankin scale was used to measure the clinical outcomes, comparing the scores at presentation, gamma knife treatment, and the last known follow-up examination. A radiographic evaluation was used to determine the level of AVM nidus involution after the procedure. RESULTS: The present study identified 16 patients with ruptured high-grade AVMs of high surgical risk. All the patients had undergone immediate embolization with delayed SRS for treatment of the hemorrhage and nidus of the AVM. A statistically significant proportion of patients showed marked improvement in the modified Rankin scale scores. No subsequent repeat hemorrhage or any associated complications after embolization occurred in any patient. CONCLUSION: These findings warrant consideration of endovascular embolization with adjuvant SRS as a powerful treatment option for cases with high surgical morbidity due to AVM characteristics.
Authors: Franziska Loebel; Antonio Pontoriero; Anne Kluge; Giuseppe Iatì; Gueliz Acker; Markus Kufeld; Alberto Cacciola; Stefano Pergolizzi; Sergio Vinci; Sara Lillo; Ran Xu; Carmen Stromberger; Volker Budach; Peter Vajkoczy; Carolin Senger; Alfredo Conti Journal: PLoS One Date: 2022-09-22 Impact factor: 3.752
Authors: Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Jong Hee Chang; Jin Woo Chang; Hyun Ho Jung Journal: J Clin Med Date: 2021-05-19 Impact factor: 4.241
Authors: Myung Ji Kim; So Hee Park; Keun Young Park; Hyun Ho Jung; Jong Hee Chang; Jin Woo Chang; Jae Whan Lee; Won Seok Chang Journal: J Clin Med Date: 2020-05-02 Impact factor: 4.241